Results 221 to 230 of about 64,742 (346)

Performance of continuous glucose monitoring systems (CGMs) during commercial flights in T1DM: A within‐subject comparative pilot study

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Continuous glucose monitoring (CGM) systems are increasingly used, but their accuracy under flight‐conditions remains insufficiently studied. We assessed sensor accuracy of four CGMs during in‐flight (mid‐haul) and ground conditions.
Renald Meçani   +14 more
wiley   +1 more source

Control of Dental Plaque and Gingival Inflammation by Natural Ingredients-Based Mouthwash. [PDF]

open access: yesDent J (Basel)
Dutot M   +5 more
europepmc   +1 more source

Dual action of imeglimin on insulin secretion and sensitivity in type 2 diabetes

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Imeglimin is a novel oral hypoglycemic agent approved for the treatment of type 2 diabetes in Japan, with dual actions to enhance insulin secretion and improve insulin sensitivity, suggested by preclinical evidence. However, the effect of imeglimin on tissue‐specific insulin sensitivity and glucose kinetics using glucose tracers is ...
Tsubasa Tajima   +10 more
wiley   +1 more source

Impact of digital supportive supervision (DiSS) on the extent of maternal and child healthcare service utilisation in India: a sequential mixed-methods quasi-experimental study. [PDF]

open access: yesBMJ Open
Sharda S   +13 more
europepmc   +1 more source

International clinical opinion on transparency, standardisation, and calibration alignment in the performance evaluation of systems for continuous glucose monitoring

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Continuous glucose monitoring (CGM) is now central to diabetes management, yet variation in how respective medical products are evaluated limits meaningful comparison between CGM systems. Three barriers currently constrain reliable interpretation of glucose‐derived measures.
John S. Pemberton   +20 more
wiley   +1 more source

Dynamic Threshold MOSFET Based Comparators

open access: yesInternational Journal for Research in Applied Science and Engineering Technology, 2021
openaire   +1 more source

Frontline Therapy in Diffuse Large B‐Cell Lymphoma: Evolving Standards, Biological Insights, and Future Directions

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Diffuse large B‐cell lymphoma (DLBCL) remains the most common aggressive lymphoma, representing a biologically heterogeneous disease with diverse clinical behaviors. For more than two decades, R‐CHOP has been the cornerstone of frontline treatment, curing approximately two‐thirds of patients.
Mamdouh Skafi   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy